Cardiovascular health research priorities in the United Arab Emirates.
United Arab Emirates
cardiovascular diseases
cardiovascular health
nominal group technique
research priorities
Journal
Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579
Informations de publication
Date de publication:
2023
2023
Historique:
received:
23
12
2022
accepted:
20
02
2023
medline:
28
3
2023
entrez:
27
3
2023
pubmed:
28
3
2023
Statut:
epublish
Résumé
Cardiovascular diseases (CVDs) are a leading cause of morbidity and mortality in the United Arab Emirates (UAE) and have been prioritized for intervention by healthcare authorities and clinicians. To identify clinically relevant research priorities for the treatment and prevention of CVDs in the UAE. This study used the nominal group technique to identify CVD-related research priorities. Participants were 37 experts from UAE hospitals, academic and research institutions, CVD associations, and paramedical organizations. Initially, 138 research topics were suggested by participating experts. These topics were then refined to identify the most important research priorities related to CVD prevention and treatment. The top research priority areas were: development of evidence-based, customized algorithms for CVD prevention and in-hospital emergency interventions; the availability, accessibility, and affordability of CVD treatment and rehabilitation; identification of relationships between CVDs, lifestyle factors, and mental health; efficacy and constraints in the management of cardiac emergencies; and epidemiological studies that trace CVD in the UAE. The identified research priorities will guide a more informed research program for CVD treatment and prevention in the UAE. Funding opportunities and support for researchers should be prioritized for these identified research areas.
Sections du résumé
Background
Cardiovascular diseases (CVDs) are a leading cause of morbidity and mortality in the United Arab Emirates (UAE) and have been prioritized for intervention by healthcare authorities and clinicians.
Aim
To identify clinically relevant research priorities for the treatment and prevention of CVDs in the UAE.
Methods
This study used the nominal group technique to identify CVD-related research priorities. Participants were 37 experts from UAE hospitals, academic and research institutions, CVD associations, and paramedical organizations.
Results
Initially, 138 research topics were suggested by participating experts. These topics were then refined to identify the most important research priorities related to CVD prevention and treatment. The top research priority areas were: development of evidence-based, customized algorithms for CVD prevention and in-hospital emergency interventions; the availability, accessibility, and affordability of CVD treatment and rehabilitation; identification of relationships between CVDs, lifestyle factors, and mental health; efficacy and constraints in the management of cardiac emergencies; and epidemiological studies that trace CVD in the UAE.
Conclusion
The identified research priorities will guide a more informed research program for CVD treatment and prevention in the UAE. Funding opportunities and support for researchers should be prioritized for these identified research areas.
Identifiants
pubmed: 36969683
doi: 10.3389/fpubh.2023.1130716
pmc: PMC10035787
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1130716Informations de copyright
Copyright © 2023 Ghader, Al-Yateem, Dalibalta, Razzak, Rahman, Al Matrooshi, Al Shaya and Al Marzouqi.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
BMJ Open. 2018 Mar 2;8(3):e019726
pubmed: 29500214
J Med Screen. 2012 Dec;19(4):201-5
pubmed: 23293165
Circulation. 2008 Jun 10;117(23):3031-8
pubmed: 18541753
Circ Res. 2017 Sep 1;121(6):677-694
pubmed: 28860318
J Am Heart Assoc. 2014 Sep 22;3(5):e000504
pubmed: 25246447
Arch Acad Emerg Med. 2019 Jun 3;7(1):34
pubmed: 31555764
BMJ Open. 2020 Dec 12;10(12):e038667
pubmed: 33310793
Am J Med. 2016 Nov;129(11):1145-1148
pubmed: 27288855
BMC Health Serv Res. 2017 Sep 20;17(1):672
pubmed: 28931388
Front Physiol. 2016 Jan 26;7:2
pubmed: 26858650
Health Res Policy Syst. 2017 Oct 9;15(1):87
pubmed: 28992810
Circulation. 2019 Feb 26;139(9):e44-e54
pubmed: 30674212
Obes Rev. 2007 Jan;8(1):15-20
pubmed: 17212792
Lancet. 2014 Jan 25;383(9914):356-67
pubmed: 24452044
PLoS One. 2020 Jan 24;15(1):e0228031
pubmed: 31978187
Int J Technol Assess Health Care. 2009 Jul;25(3):241-8
pubmed: 19619341
BMC Pediatr. 2020 May 25;20(1):245
pubmed: 32450837
Heart Views. 2019 Oct-Dec;20(4):146-151
pubmed: 31803370